Annotation Detail for NUMBL
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04330 | Notch signaling pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NUMBL mRNA | affects expression | 17562736
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUMBL mRNA | decreases expression | 20018196
|
D003024 |
Clozapine |
Clozapine results in decreased expression of NUMBL mRNA | decreases expression | 18797397
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of NUMBL mRNA | decreases expression | 18797397
|
C076029 |
olanzapine |
olanzapine results in decreased expression of NUMBL mRNA | decreases expression | 18797397
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUMBL mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NUMBL mRNA | affects binding|decreases expression|increases activity | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.47 | 16160616 14617031 12649775 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.36 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.43 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.43 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.43 | 17069543 18685284 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.40 | 3084413 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.37 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.75 | 10977129 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.77 | 16772815 18071103 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.93 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.38 | 17123785 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.19 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.90 | 11575062 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.89 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.03 | 16402076 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
6.07 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.65 | 11834606 18713872 19416960 19085960 17522070 19164858 11461765 16393943 19739265 19420014 12958197 15968718 16227642 11743745 11287661 16485898 16081117 11739529 10663392 12594235 14725611 11529661 16781746 17562736 17906064 16177239 12153990 10774834 14986274 14550746 10915739 12392966 12705907 15619225 18071297 2444490 11421492 19923254 16109766 19370779 12540782 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.62 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.40 | 16402076 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.09 | 19236843 20131406 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.19 | 16983495 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 19772884 19176532 18467677 16221962 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.95 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.37 | 16046005 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.69 | 17933447 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.36 | 12587719 15629191 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.18 | 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 11587558 16610002 19460945 16611625 12587719 19784758 12969438 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.54 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.91 | 16377806 20007298 15890375 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.97 | 20210726 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.98 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
16.33 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
16.33 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
16.33 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.72 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.68 | 19142101 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.14 | 18514411 |
MESH:D009765 |
Obesity |
|
Clozapine |
8.04 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
olanzapine |
8.04 | 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
8.04 | 20558911 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.65 | 16870215 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
13.25 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
13.25 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.90 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.90 | 11575062 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
6.13 | 18855531 20168265 17726453 19369910 17667964 18806925 11763009 11151749 20107430 17123785 20580759 20452607 20521326 16141801 20521320 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
6.13 | 18513383 19369910 20107430 1830565 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
6.13 | 20521326 20107430 17726453 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
12.26 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
12.26 | 20210726 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.33 | 10982225 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
11.32 | 20564506 20107430 20521320 17502770 16141801 16402076 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
11.32 | 17933447 19434072 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.54 | 17933447 |
Pathway ID |
Pathway Name |
---|
KEGG:04330 |
Notch signaling pathway |